Docket Room
HR 7050·Federal·house

Homeopathic Drug Product Safety, Quality, and Transparency Act

In CommitteeFiled Jan 14, 2026
Sponsor: Rep. Sessions, Pete [R-TX-17] (R)
Latest Action

Referred to the House Committee on Energy and Commerce.

Jan 14, 2026

Summary

The bill adds a new section to the Federal Food, Drug, and Cosmetic Act that defines homeopathic drug products and sets safety, quality, and transparency standards based on the Homeopathic Pharmacopoeia or accredited consensus standards. It limits the application of most existing FDA provisions to these products unless they align with the new standards, and it allows manufacturers to petition for exemptions or variances. The goal is to protect consumers while preserving access to homeopathic medicines.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when HR 7050 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice